RICCARDO GAVIOLI
Nationality: Italian
Born: April 14th, 1958
Positions:
2001- Professor of Biochemistry, University of Ferrara.
2003- Coordinator of the International PhD in Experimental Oncology
2003- Coordinator of the Italian Group of Biochemistry Immunology
1993-Head of the Molecular and Cellular and Molecular Oncology Lab, Dept. Biochemistry and Molecular Biology, University of Ferrara
2003- Coordinator of a subproject of the Italian concerted action in HIV/AIDS vaccine development (ICAV)
2003- President of the evaluation group of the Degree Course in Chemistry and Pharmaceutical Technologies
Education:
1983: Degree in Chemistry and Pharmaceutical Technology, University of Ferrara.
1990: PhD degree in Biochemistry.
1990-1992: 2 years Post-Doc at the Tumor Biology Department, Karolinska Institute, Stockholm.
2000-2001: Visiting Professor at the Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm.
Working Labs:
Institute of Chimica Biologica of Ferrara (Italy); Cancer Research Institute of Genova (Italy); Dept. of Tumor Biology, Karolinska Inst, Stockholm, (Sweden); Dept. of Cancer Studies, Birmingham, UK; Dept. of Biochemistry and Molecular Biology, Laboratory of Cellular and Molecular Oncology, University of Ferrara, Italy; Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm (Sweden).
Fellowships
1989: Italian Biochemistry Society; 1990: Swedish Institute, Sweden; 1991: Anna Villa Rusconi, Varese Italy; 1992: Cancer Fonden, Sweden; 1999: Cancer Foundation USA.
Field of interest and major contributions
Identification of virus-specific CTL responses and processing and presentation of immunogenic peptides in normal cell lines, viral infected cells and tumours.
Contributions to the fields of biochemistry, tumour biology, virology and immunology: Identification of MHC-I restricted CTL responses to viruses (PNAS 1992, Science 1993,J. Virol. 1993, PNAS 1993, J. Exp. Med 1997, Eur. J. Immunol. 2002); Identification of CTL peptide analogue with improved immunogencity (J. Immunol. 1999, Eur. J. Immunol. 1999, J. Immunol. 2000); Analysis of antigen processing in tumours, viral infected cells and antigen presenting cells (Nature Cell Biol. 2001, Int. J. Cancer 2002, J. Med. Chem. 2004, Eur. J. Immunol. 2004); Immunogenicity and new delivery systems of HIV vaccines (Vaccine 2003, Vaccine 2003, Vaccine 2004).
Grants as principal investigator:
Italian Association for Cancer Research (AIRC); Istituto Superiore di Sanità-AIDS projects; University of Ferrara; EU; Ministero della Ricerca Scientifica (MURST)
Patents:
1. Use of microparticles for antigen delivery, Ensoli B., Caputo A., Gavioli R., Tondelli L., Laus M., Sparnacci K. Priority GB/03.11.03/GBA 0325624. Application n°/Patent n°: 04797558.6-2108-EP2004012421, 2004.
2. Vaccines containing the HIV Tat protein as an adjuvant for the enhancement of cytotoxic-T cell responses, Ensoli B., Gavioli R., Caputo A. Priority GB/10.10.03/GBA 0323840. Application n°/Patent n°: 04766004.8-2402-EP2004011950, 2004.
Nationality: Italian
Born: April 14th, 1958
Positions:
2001- Professor of Biochemistry, University of Ferrara.
2003- Coordinator of the International PhD in Experimental Oncology
2003- Coordinator of the Italian Group of Biochemistry Immunology
1993-Head of the Molecular and Cellular and Molecular Oncology Lab, Dept. Biochemistry and Molecular Biology, University of Ferrara
2003- Coordinator of a subproject of the Italian concerted action in HIV/AIDS vaccine development (ICAV)
2003- President of the evaluation group of the Degree Course in Chemistry and Pharmaceutical Technologies
Education:
1983: Degree in Chemistry and Pharmaceutical Technology, University of Ferrara.
1990: PhD degree in Biochemistry.
1990-1992: 2 years Post-Doc at the Tumor Biology Department, Karolinska Institute, Stockholm.
2000-2001: Visiting Professor at the Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm.
Working Labs:
Institute of Chimica Biologica of Ferrara (Italy); Cancer Research Institute of Genova (Italy); Dept. of Tumor Biology, Karolinska Inst, Stockholm, (Sweden); Dept. of Cancer Studies, Birmingham, UK; Dept. of Biochemistry and Molecular Biology, Laboratory of Cellular and Molecular Oncology, University of Ferrara, Italy; Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm (Sweden).
Fellowships
1989: Italian Biochemistry Society; 1990: Swedish Institute, Sweden; 1991: Anna Villa Rusconi, Varese Italy; 1992: Cancer Fonden, Sweden; 1999: Cancer Foundation USA.
Field of interest and major contributions
Identification of virus-specific CTL responses and processing and presentation of immunogenic peptides in normal cell lines, viral infected cells and tumours.
Contributions to the fields of biochemistry, tumour biology, virology and immunology: Identification of MHC-I restricted CTL responses to viruses (PNAS 1992, Science 1993,J. Virol. 1993, PNAS 1993, J. Exp. Med 1997, Eur. J. Immunol. 2002); Identification of CTL peptide analogue with improved immunogencity (J. Immunol. 1999, Eur. J. Immunol. 1999, J. Immunol. 2000); Analysis of antigen processing in tumours, viral infected cells and antigen presenting cells (Nature Cell Biol. 2001, Int. J. Cancer 2002, J. Med. Chem. 2004, Eur. J. Immunol. 2004); Immunogenicity and new delivery systems of HIV vaccines (Vaccine 2003, Vaccine 2003, Vaccine 2004).
Grants as principal investigator:
Italian Association for Cancer Research (AIRC); Istituto Superiore di Sanità-AIDS projects; University of Ferrara; EU; Ministero della Ricerca Scientifica (MURST)
Patents:
1. Use of microparticles for antigen delivery, Ensoli B., Caputo A., Gavioli R., Tondelli L., Laus M., Sparnacci K. Priority GB/03.11.03/GBA 0325624. Application n°/Patent n°: 04797558.6-2108-EP2004012421, 2004.
2. Vaccines containing the HIV Tat protein as an adjuvant for the enhancement of cytotoxic-T cell responses, Ensoli B., Gavioli R., Caputo A. Priority GB/10.10.03/GBA 0323840. Application n°/Patent n°: 04766004.8-2402-EP2004011950, 2004.
